Գլխավոր Թոփ լուրեր Լրահոս Վիդեո Թրենդ

Idram is now available in Yerevan CityNew Offer for Residents of 28 Cities with 5G Network Joining Ucom Ucom Joins the Regional Forum “DemArDem: Dialogue of Generations” AraratBank: The Only Victory is the Smile of a Recovered Child Financially Literate with Idram Junior IDBank new branch is in the City of ArtashatNew campaign from IDBank on the occasion of Client’s Day Ucom Celebrates International Client's Day, Strengthening Ties with Subscribers Ucom’s Fixed Network Now Available in Yeghvard 4,664,972 AMD to QaylTech. The beneficiary of The Power of One Dram for March is the Heroes Rehabilitation City Ucom Fellowship Incubation Program Concludes with Inspiring Closing Ceremony and Awards Event Preferential registration for the FINTECH360conference is available until March 15 Face to Face with “The Power of One Dram”: The Regional Forum on Dialogue of Generations is just a few days away Ucom Launches a New Major Network Upgrade Project Ucom's General Director Spoke about Personal Growth at the Armenian Businessman 2025 Event Pay with Idram at Yerevan Mall and Win an idplus Gift Card!Ucom Presents a New Exclusive Offer for the Spring Holidays Four Badalyan Brothers Enterprises Ranked Among Armenia’s Top 1,000 Taxpayers Ucom’s General Director Shares his Experience with Cybersecurity Training Course Participants Customer Appreciation Day at IDBankIDBank issues the 2nd tranche of dollar bonds of 2025 New Banking, Even More Convenient: Idram&IDBank AraratBank and Aren Mehrabyan Foundation Strengthen their Partnership On International Mother Language Day, AraratBank Summarizes Results of Unique Project with Matenadaran Ameriabank named Armenia’s Best Investment Bank for 2025 by Global Finance Exclusive Benefits for Businesses: IDBank's New Visa Signature Business Card Flight on the Wings of a Book: Bvik and Idram Promote the Love of Reading AraratBank Receives Prestigious Partner of the Year Award from Ria Money TransferFINTECH360 International Conference will be held in April in Yerevan Unibank placed subordinated bonds ahead of schedule 4,632,795 AMD for the DigiCode-2025 Competition – February's Beneficiary is QaylTech Ucom Fellowship Program Participants Visit Ucom Headquarters for Leadership Insights New IDBank Branch in ArmavirPay with IDBank Mastercard and get 5% idcoin Hayk Melikyan's solo concert dedicated to contemporary Armenian and swiss composers AraratBank: Caring for the Nation's Defenders IDBank issues the 1st tranche of dollar bonds of 2025AraratBank Wins Mastercard's Excellence in SME Banking Services AwardIDBank concluded the raffle of 5 iPhone 16 ProUcom Accelerates Digital Transformation with Cerillion's Cutting Edge Convergent PlatformWhen a one dram transforms into a mighty force: "The Power of One Dram" wraps up 2024 I primi cavalieri dell'Apocalisse armenaUnibank opens new branch in Malatya-Sebastia district of Yerevan5,119,225 AMD to the Children of the Regions Foundation. January's beneficiary is the "Armath" educational program Ameriabank Raises $200 Million from IFC, Marking the Largest Transaction by IFC ever with a Financial Institution in ArmeniaUcom Receives the International ISO 37001 Standard to Prevent, Detect and Address BriberyMay the Holiday Warm Hearts: Idram and IDBank Support the Children of HeroesBeneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity
Lifestyle

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.